Skip to main content

Table 1 Encapsulation and loading of antigen/immunostimulant in NPs

From: Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology

Encapsulants

%Encapsulation efficiency

%Loading

Assay

Amount of encapsulant in NPs used for vaccination (µg/mg NP)

LPS

16.1

0.4

TBA

4.0

IpaC

21.7

1.0

BCA

10.0

IpaB

60.0

3.1

BCA

31.0